NEKTAR THERAPEUTICS — Director's Dealing 2016

Feb 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2016-02-03

Reporting Person: Gergel Ivan P. (SVP & Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-03	Stock Option	$12.21	A	100000	Acquired	2024-02-02	Common Stock (100000)	Direct

Footnotes

F1: This stock option vests over a period of 4 years with 25% of the option vesting on the first anniversary of the grant date and the remaining 75% of the option in monthly installments over the 3-year period thereafter.